From Wikipedia, the free encyclopedia
Pharmaceutical drug classification
ATC code J06 Immune sera and immunoglobulins is a therapeutic subgroup of the
Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the
World Health Organization (WHO) for the classification of
drugs and other medical products.
[1]
[2]
[3] Subgroup J06 is part of the anatomical group
J Antiinfectives for systemic use.
[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
J06AA Immune sera
- J06AA01
Diphtheria antitoxin
- J06AA02
Tetanus antitoxin
- J06AA03
Snake venom antiserum
- J06AA04
Botulinum antitoxin
- J06AA05
Gas-gangrene sera
- J06AA06
Rabies serum
J06B Immunoglobulins
J06BA Immunoglobulins, normal human
- J06BA01 Immunoglobulins, normal human, for extravascular administration
- J06BA02 Immunoglobulins, normal human, for intravascular administration
- J06BB01
Anti-D (rh) immunoglobulin
- J06BB02
Tetanus immunoglobulin
- J06BB03
Varicella/zoster immunoglobulin
- J06BB04
Hepatitis B immunoglobulin
- J06BB05
Rabies immunoglobulin
- J06BB06
Rubella immunoglobulin
- J06BB07
Vaccinia immunoglobulin
- J06BB08
Staphylococcus immunoglobulin
- J06BB09
Cytomegalovirus immunoglobulin
- J06BB10
Diphtheria immunoglobulin
- J06BB11
Hepatitis A immunoglobulin
- J06BB12
Encephalitis, tick-borne immunoglobulin
- J06BB13
Pertussis immunoglobulin
- J06BB14
Morbilli immunoglobulin
- J06BB15
Parotitis immunoglobulin
- J06BB19
Anthrax immunoglobulin
- J06BB30 Combinations
J06BC Antibacterial monoclonal antibodies
- J06BC01
Nebacumab
- J06BC02
Raxibacumab
- J06BC03
Bezlotoxumab
- J06BC04
Obiltoxaximab
J06BD Antiviral monoclonal antibodies
- J06BD01
Palivizumab
- J06BD02
Motavizumab
- J06BD03
Tixagevimab and cilgavimab
- J06BD04
Ansuvimab
- J06BD05
Sotrovimab
- J06BD06
Regdanvimab
- J06BD07
Casirivimab and imdevimab
- J06BD08
Nirsevimab
See also
- Immune sera and immunoglobulins for veterinary use are in the
ATCvet group
QI.
References